Celularity Inc
CELUW
19 hedge funds and large institutions have $438K invested in Celularity Inc in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 3 closing their positions.
0.46% less ownership
Funds ownership: 5.07% → 4.61% (-0.46%)
5% less funds holding
Funds holding: 20 → 19 (-1)
33% less capital invested
Capital invested by funds: $655K → $438K (-$217K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
86% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 7
Top Buyers
| 1 |
Walleye Capital
New York
|
+$4.68K |
| 2 |
Corient Private Wealth
Miami,
Florida
|
+$1.23K |
Top Sellers
CELUW Hedge Fund Activity: Q1 2023 in Review
19 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Celularity Inc (CELUW) for Q1 2023, worth a combined $438K — down 33% from $655K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CELUW and 2 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 1 added.
The largest buyer was Walleye Capital, adding an estimated $4.68K. The largest seller was RPO LLC, cutting an estimated $19.6K.
- 19 institutional investors held Celularity Inc (CELUW) as of Q1 2023, down from 20 in Q4 2022.
- Funds reported $438K of Celularity Inc stock for Q1 2023, down 33% quarter-over-quarter.
- 2 funds opened new Celularity Inc positions in Q1 2023 and 3 closed out, a net change of -1 holder.
- The largest Celularity Inc buyer in Q1 2023 was Walleye Capital, an estimated $4.68K added.
- The largest Celularity Inc seller in Q1 2023 was RPO LLC, an estimated $19.6K sold.
Based on aggregated 13F filings for Q1 2023.